Related Experiment Video
Updated: Apr 1, 2026

Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
Immune dysregulation in the functional gastrointestinal disorders
Simon Keely1, Marjorie M Walker2, Ellen Marks1
1School of Biomedical Sciences & Pharmacy, University of Newcastle & Vaccine and Asthma (VIVA) Program, Hunter Medical Research Institute, Callaghan, NSW, Australia.
Functional gastrointestinal disorders (FGIDs) often lack clear causes, but emerging research suggests inflammation may play a role. This study explores immune involvement in FGIDs, proposing a new hypothesis for their underlying immunopathology.
Area of Science:
- Gastroenterology
- Immunology
- Pathophysiology
Background:
- Functional gastrointestinal disorders (FGIDs) represent a significant patient burden, characterized by chronic symptoms without identifiable organic pathology.
- Current treatments for FGIDs primarily manage symptoms due to a lack of understanding of underlying mechanisms.
- Growing evidence suggests an inflammatory component in specific FGID patient groups, including irritable bowel syndrome and functional dyspepsia.
Purpose of the Study:
- To review current knowledge on immune system involvement in FGIDs.
- To identify commonalities in immune responses across different FGIDs.
- To propose a novel hypothesis for the immunopathological basis of FGIDs.
Main Methods:
- Literature review of studies investigating immune mechanisms in FGIDs.
- Comparative analysis of inflammatory markers and immune cell involvement in FGIDs.
- Synthesis of existing data to formulate a new hypothesis.
Main Results:
- FGIDs are broadly categorized into organic and functional diseases, with functional disorders being more prevalent.
- Immune system dysregulation and inflammation are increasingly recognized as potential contributors to FGID pathogenesis.
- Commonalities in immune involvement exist across various FGIDs, suggesting shared underlying pathways.
Conclusions:
- Inflammation is a key factor to consider in the pathophysiology of FGIDs.
- A unifying immunopathological hypothesis for FGIDs may provide new therapeutic targets.
- Further research into immune mechanisms could lead to more effective treatments for chronic gastrointestinal symptoms.
More Related Videos
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Gastrointestinal Motility Disorders
Other Disorders of Digestive System
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

